Latest Biotechnology News and Updates : Biotechnology updates, Biotechnology News , Biotechnology around the world

Nishadil

Washington | 11°C (overcast clouds)

A New Dawn in Cancer Detection: FDA Panel Backs GRAIL's Galleri Multi-Cancer Blood Test

Top story

A New Dawn in Cancer Detection: FDA Panel Backs GRAIL's Galleri Multi-Cancer Blood Test

In focus

Latest feed

The Quiet Revolution: Why Biotech VCs Are Now Spotting Gold in Osteoporosis Treatments

Stanford’s AI‑Powered Virtual Biotech: 37,000 Agents Hunting New Therapies

Why AI Is Fast‑Tracking Theory but Struggling to Keep Up in the Lab

Beyond Nature's Blueprint: AI Forges a New World of Molecules

Latest headlines

Hansa Biopharma Illuminates a Path Forward: Unpacking the Vision from Their Capital Markets Day

Hansa Biopharma Illuminates a Path Forward: Unpacking the Vision from Their Capital Markets Day

Smart Nanoparticles Deliver mRNA Straight to Tumors

Smart Nanoparticles Deliver mRNA Straight to Tumors

Smart Nanoparticles Carry mRNA Straight to Tumors, Offering New Hope in Cancer Therapy

Smart Nanoparticles Carry mRNA Straight to Tumors, Offering New Hope in Cancer Therapy

Vera Therapeutics' Trutakna Achieves Landmark Success in Phase 3 Trial for IgA Nephropathy

Vera Therapeutics' Trutakna Achieves Landmark Success in Phase 3 Trial for IgA Nephropathy

Trump’s Secret Pharma Deals Threaten ‘Most‑Favored Nation’ Savings

Trump’s Secret Pharma Deals Threaten ‘Most‑Favored Nation’ Savings

Trump’s Quiet Pharma Deals Threaten Big Medicare Savings

Trump’s Quiet Pharma Deals Threaten Big Medicare Savings

Merck's Master Plan: Building a Multi-Billion Dollar Future Beyond Keytruda

Merck's Master Plan: Building a Multi-Billion Dollar Future Beyond Keytruda

Biotech Conclave 2026: VIT Chennai Teams Up with The Hindu to Map the Future of Biotechnology

Biotech Conclave 2026: VIT Chennai Teams Up with The Hindu to Map the Future of Biotechnology

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

Roivant’s Mosliciguat Shows Promise in Pulmonary Hypertension Trial

Roivant’s Mosliciguat Shows Promise in Pulmonary Hypertension Trial

When a Breakthrough Pancreatic Cancer Drug Hits the Market, Insurance Still Plays Catch‑up

When a Breakthrough Pancreatic Cancer Drug Hits the Market, Insurance Still Plays Catch‑up

US‑India TRUST Fellowship Launched in Bengaluru – A New Era of Tech Collaboration

US‑India TRUST Fellowship Launched in Bengaluru – A New Era of Tech Collaboration

Tyra Biosciences Stock Jumps as Crucial Bladder Cancer Drug Data Looms

Tyra Biosciences Stock Jumps as Crucial Bladder Cancer Drug Data Looms

Maharashtra and Australia set sights on a joint biomanufacturing push

Maharashtra and Australia set sights on a joint biomanufacturing push

A New Chapter in Xenotransplantation: Gene‑Edited Pig Kidneys Bridge to Human Organs

A New Chapter in Xenotransplantation: Gene‑Edited Pig Kidneys Bridge to Human Organs

FDA Intensifies Crackdown on Unproven Stem Cell and Regenerative Medicine Clinics

FDA Intensifies Crackdown on Unproven Stem Cell and Regenerative Medicine Clinics

A New Dawn for Merrimack: Former Anheuser-Busch Brewery Site Acquired by Biotech Innovator United Therapeutics

A New Dawn for Merrimack: Former Anheuser-Busch Brewery Site Acquired by Biotech Innovator United Therapeutics

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

Krystal Biotech Shines Bright: RBC Capital Markets Sees Major Upside

Krystal Biotech Shines Bright: RBC Capital Markets Sees Major Upside

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals

Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals

Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter

Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter

After-Hours Jitters: Why AMAT, DLO, and ZNTL Saw Dips Despite a Bullish Market Day

After-Hours Jitters: Why AMAT, DLO, and ZNTL Saw Dips Despite a Bullish Market Day

A Revolutionary Shield: Unlocking Snakebite Antidotes from Venomous Blood Itself

A Revolutionary Shield: Unlocking Snakebite Antidotes from Venomous Blood Itself

A Glimmer of Hope: New Alzheimer's Drug Shows Remarkable Safety in Early Trial

A Glimmer of Hope: New Alzheimer's Drug Shows Remarkable Safety in Early Trial

The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

India’s Experts Call for an Overhaul of GM & Genome‑Edited Crop Regulations

India’s Experts Call for an Overhaul of GM & Genome‑Edited Crop Regulations

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

CRISPR Therapeutics: On the Cusp of a New Era in Medicine

CRISPR Therapeutics: On the Cusp of a New Era in Medicine

Most-Wanted Fugitive Turns Out to Be a Biotech C‑Level Executive

Most-Wanted Fugitive Turns Out to Be a Biotech C‑Level Executive

A Glimmer of Hope: ARTIDIS Kicks Off Groundbreaking OPTIMAL-E Trial for Prostate Cancer

A Glimmer of Hope: ARTIDIS Kicks Off Groundbreaking OPTIMAL-E Trial for Prostate Cancer

A New Chapter in Prostate Cancer Care: First Patients Dosed in Pivotal OPTIMAL-E Trial

A New Chapter in Prostate Cancer Care: First Patients Dosed in Pivotal OPTIMAL-E Trial

Daraxonrasib and the Fight Against Pancreatic Cancer: Hope Meets Hurdles

Daraxonrasib and the Fight Against Pancreatic Cancer: Hope Meets Hurdles

Load more